Mike Stratton
Director/Miembro de la Junta en Wellcome Trust Sanger Institute .
Perfil
Mike Stratton is the founder of Quotient Therapeutics Ltd., which was founded in 2022.
He is currently the Director at Wellcome Trust Sanger Institute.
Cargos activos de Mike Stratton
| Empresas | Cargo | Inicio |
|---|---|---|
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Mike Stratton.
| Empresas | Cargo | Fin |
|---|
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Mike Stratton
